Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical Cannabis and POTS for Chronic Non-Cancer Pain
NCT04827992Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2021
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of cannabis in chronic pain and opioid use disorder (OUD) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoints: Prescription Monitoring Program Verified Opioid Dose at 24 weeks and Pain, Enjoyment, General Activity Scale at 24 weeks. Started Aug 2021; status: completed.
02
Drugs
cannabis
03
Conditions
chronic painopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04827992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04827992.